img

Global Enramycin Premix Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Enramycin Premix Market Insights, Forecast to 2034

Enramycin premix is formulated with enramycin, rice bran oil and corn flour. This product is a gray or gray-brown powder with a special odor. It is fermented by actinomycetes and is an unsaturated fatty acid. Polypeptide antibiotics combined with more than a dozen amino acids. It has a strong inhibitory effect on Gram-positive bacteria, and it is not easy to develop drug resistance after long-term use. It can change the distribution of bacterial communities in the intestinal tract, is conducive to the digestion and absorption of feed nutrients, promotes animal growth and improves feed conversion rate, so it is recommended as a pharmaceutical feed additive by many countries in the world. Enramycin is not easily absorbed, so there are fewer drug residues in the body of livestock and poultry.
The global Enramycin Premix market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Enramycin Premix is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Enramycin Premix is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Enramycin Premix is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key manufacturers of Enramycin Premix include Takeda, AdvaCare, Phiphar Healthcare, Boehringer Ingelheim, Eli Lilly and Company, Ravioza Biotech, Zhejiang Dayang Biology Technology, Bornsun Bioengineering and Shandong Shengli Bioengineering, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Enramycin Premix production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2033.
In terms of consumption side, this report focuses on the sales of Enramycin Premix by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2033.

Report Includes


This report presents an overview of global market for Enramycin Premix, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of Enramycin Premix, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Enramycin Premix, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Enramycin Premix sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Enramycin Premix market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2033. Evaluation and forecast the market size for Enramycin Premix sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Takeda, AdvaCare, Phiphar Healthcare, Boehringer Ingelheim, Eli Lilly and Company, Ravioza Biotech, Zhejiang Dayang Biology Technology, Bornsun Bioengineering and Shandong Shengli Bioengineering, etc.



By Company


Takeda
AdvaCare
Phiphar Healthcare
Boehringer Ingelheim
Eli Lilly and Company
Ravioza Biotech
Zhejiang Dayang Biology Technology
Bornsun Bioengineering
Shandong Shengli Bioengineering
Apeloa Pharmaceutical
Hvsen Biotechnology
Segment by Type
Contains Enramycin 4%
Contains Enramycin 8%

Segment by Application


Pig Fodder
Chicken Fodder
Others

Production by Region


North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Enramycin Premix production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3Sales (consumption), revenue of Enramycin Premix in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4Detailed analysis of Enramycin Premix manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9China by type and by application sales and revenue for each segment.
Chapter 10Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enramycin Premix sales, revenue, price, gross margin, and recent development, etc.
Chapter 13Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Enramycin Premix Product Introduction
1.2 Market by Type
1.2.1 Global Enramycin Premix Market Size by Type, 2018 VS 2022 VS 2033
1.2.2 Contains Enramycin 4%
1.2.3 Contains Enramycin 8%
1.3 Market by Application
1.3.1 Global Enramycin Premix Market Size by Application, 2018 VS 2022 VS 2033
1.3.2 Pig Fodder
1.3.3 Chicken Fodder
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Enramycin Premix Production
2.1 Global Enramycin Premix Production Capacity (2018-2033)
2.2 Global Enramycin Premix Production by Region: 2018 VS 2022 VS 2033
2.3 Global Enramycin Premix Production by Region
2.3.1 Global Enramycin Premix Historic Production by Region (2018-2023)
2.3.2 Global Enramycin Premix Forecasted Production by Region (2024-2033)
2.3.3 Global Enramycin Premix Production Market Share by Region (2018-2033)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Enramycin Premix Revenue Estimates and Forecasts 2018-2033
3.2 Global Enramycin Premix Revenue by Region
3.2.1 Global Enramycin Premix Revenue by Region: 2018 VS 2022 VS 2033
3.2.2 Global Enramycin Premix Revenue by Region (2018-2023)
3.2.3 Global Enramycin Premix Revenue by Region (2024-2033)
3.2.4 Global Enramycin Premix Revenue Market Share by Region (2018-2033)
3.3 Global Enramycin Premix Sales Estimates and Forecasts 2018-2033
3.4 Global Enramycin Premix Sales by Region
3.4.1 Global Enramycin Premix Sales by Region: 2018 VS 2022 VS 2033
3.4.2 Global Enramycin Premix Sales by Region (2018-2023)
3.4.3 Global Enramycin Premix Sales by Region (2024-2033)
3.4.4 Global Enramycin Premix Sales Market Share by Region (2018-2033)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Enramycin Premix Sales by Manufacturers
4.1.1 Global Enramycin Premix Sales by Manufacturers (2018-2023)
4.1.2 Global Enramycin Premix Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Enramycin Premix in 2022
4.2 Global Enramycin Premix Revenue by Manufacturers
4.2.1 Global Enramycin Premix Revenue by Manufacturers (2018-2023)
4.2.2 Global Enramycin Premix Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Enramycin Premix Revenue in 2022
4.3 Global Enramycin Premix Sales Price by Manufacturers
4.4 Global Key Players of Enramycin Premix, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Enramycin Premix Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Enramycin Premix, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Enramycin Premix, Product Offered and Application
4.8 Global Key Manufacturers of Enramycin Premix, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Enramycin Premix Sales by Type
5.1.1 Global Enramycin Premix Historical Sales by Type (2018-2023)
5.1.2 Global Enramycin Premix Forecasted Sales by Type (2024-2033)
5.1.3 Global Enramycin Premix Sales Market Share by Type (2018-2033)
5.2 Global Enramycin Premix Revenue by Type
5.2.1 Global Enramycin Premix Historical Revenue by Type (2018-2023)
5.2.2 Global Enramycin Premix Forecasted Revenue by Type (2024-2033)
5.2.3 Global Enramycin Premix Revenue Market Share by Type (2018-2033)
5.3 Global Enramycin Premix Price by Type
5.3.1 Global Enramycin Premix Price by Type (2018-2023)
5.3.2 Global Enramycin Premix Price Forecast by Type (2024-2033)
6 Market Size by Application
6.1 Global Enramycin Premix Sales by Application
6.1.1 Global Enramycin Premix Historical Sales by Application (2018-2023)
6.1.2 Global Enramycin Premix Forecasted Sales by Application (2024-2033)
6.1.3 Global Enramycin Premix Sales Market Share by Application (2018-2033)
6.2 Global Enramycin Premix Revenue by Application
6.2.1 Global Enramycin Premix Historical Revenue by Application (2018-2023)
6.2.2 Global Enramycin Premix Forecasted Revenue by Application (2024-2033)
6.2.3 Global Enramycin Premix Revenue Market Share by Application (2018-2033)
6.3 Global Enramycin Premix Price by Application
6.3.1 Global Enramycin Premix Price by Application (2018-2023)
6.3.2 Global Enramycin Premix Price Forecast by Application (2024-2033)
7 US & Canada
7.1 US & Canada Enramycin Premix Market Size by Type
7.1.1 US & Canada Enramycin Premix Sales by Type (2018-2033)
7.1.2 US & Canada Enramycin Premix Revenue by Type (2018-2033)
7.2 US & Canada Enramycin Premix Market Size by Application
7.2.1 US & Canada Enramycin Premix Sales by Application (2018-2033)
7.2.2 US & Canada Enramycin Premix Revenue by Application (2018-2033)
7.3 US & Canada Enramycin Premix Sales by Country
7.3.1 US & Canada Enramycin Premix Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 US & Canada Enramycin Premix Sales by Country (2018-2033)
7.3.3 US & Canada Enramycin Premix Revenue by Country (2018-2033)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Enramycin Premix Market Size by Type
8.1.1 Europe Enramycin Premix Sales by Type (2018-2033)
8.1.2 Europe Enramycin Premix Revenue by Type (2018-2033)
8.2 Europe Enramycin Premix Market Size by Application
8.2.1 Europe Enramycin Premix Sales by Application (2018-2033)
8.2.2 Europe Enramycin Premix Revenue by Application (2018-2033)
8.3 Europe Enramycin Premix Sales by Country
8.3.1 Europe Enramycin Premix Revenue by Country: 2018 VS 2022 VS 2033
8.3.2 Europe Enramycin Premix Sales by Country (2018-2033)
8.3.3 Europe Enramycin Premix Revenue by Country (2018-2033)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Enramycin Premix Market Size by Type
9.1.1 China Enramycin Premix Sales by Type (2018-2033)
9.1.2 China Enramycin Premix Revenue by Type (2018-2033)
9.2 China Enramycin Premix Market Size by Application
9.2.1 China Enramycin Premix Sales by Application (2018-2033)
9.2.2 China Enramycin Premix Revenue by Application (2018-2033)
10 Asia (excluding China)
10.1 Asia Enramycin Premix Market Size by Type
10.1.1 Asia Enramycin Premix Sales by Type (2018-2033)
10.1.2 Asia Enramycin Premix Revenue by Type (2018-2033)
10.2 Asia Enramycin Premix Market Size by Application
10.2.1 Asia Enramycin Premix Sales by Application (2018-2033)
10.2.2 Asia Enramycin Premix Revenue by Application (2018-2033)
10.3 Asia Enramycin Premix Sales by Region
10.3.1 Asia Enramycin Premix Revenue by Region: 2018 VS 2022 VS 2033
10.3.2 Asia Enramycin Premix Revenue by Region (2018-2033)
10.3.3 Asia Enramycin Premix Sales by Region (2018-2033)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Enramycin Premix Market Size by Type
11.1.1 Middle East, Africa and Latin America Enramycin Premix Sales by Type (2018-2033)
11.1.2 Middle East, Africa and Latin America Enramycin Premix Revenue by Type (2018-2033)
11.2 Middle East, Africa and Latin America Enramycin Premix Market Size by Application
11.2.1 Middle East, Africa and Latin America Enramycin Premix Sales by Application (2018-2033)
11.2.2 Middle East, Africa and Latin America Enramycin Premix Revenue by Application (2018-2033)
11.3 Middle East, Africa and Latin America Enramycin Premix Sales by Country
11.3.1 Middle East, Africa and Latin America Enramycin Premix Revenue by Country: 2018 VS 2022 VS 2033
11.3.2 Middle East, Africa and Latin America Enramycin Premix Revenue by Country (2018-2033)
11.3.3 Middle East, Africa and Latin America Enramycin Premix Sales by Country (2018-2033)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Takeda
12.1.1 Takeda Company Information
12.1.2 Takeda Overview
12.1.3 Takeda Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Takeda Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Takeda Recent Developments
12.2 AdvaCare
12.2.1 AdvaCare Company Information
12.2.2 AdvaCare Overview
12.2.3 AdvaCare Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 AdvaCare Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 AdvaCare Recent Developments
12.3 Phiphar Healthcare
12.3.1 Phiphar Healthcare Company Information
12.3.2 Phiphar Healthcare Overview
12.3.3 Phiphar Healthcare Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Phiphar Healthcare Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Phiphar Healthcare Recent Developments
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Company Information
12.4.2 Boehringer Ingelheim Overview
12.4.3 Boehringer Ingelheim Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Boehringer Ingelheim Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Boehringer Ingelheim Recent Developments
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Information
12.5.2 Eli Lilly and Company Overview
12.5.3 Eli Lilly and Company Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Eli Lilly and Company Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Eli Lilly and Company Recent Developments
12.6 Ravioza Biotech
12.6.1 Ravioza Biotech Company Information
12.6.2 Ravioza Biotech Overview
12.6.3 Ravioza Biotech Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Ravioza Biotech Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Ravioza Biotech Recent Developments
12.7 Zhejiang Dayang Biology Technology
12.7.1 Zhejiang Dayang Biology Technology Company Information
12.7.2 Zhejiang Dayang Biology Technology Overview
12.7.3 Zhejiang Dayang Biology Technology Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Zhejiang Dayang Biology Technology Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Dayang Biology Technology Recent Developments
12.8 Bornsun Bioengineering
12.8.1 Bornsun Bioengineering Company Information
12.8.2 Bornsun Bioengineering Overview
12.8.3 Bornsun Bioengineering Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Bornsun Bioengineering Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Bornsun Bioengineering Recent Developments
12.9 Shandong Shengli Bioengineering
12.9.1 Shandong Shengli Bioengineering Company Information
12.9.2 Shandong Shengli Bioengineering Overview
12.9.3 Shandong Shengli Bioengineering Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Shandong Shengli Bioengineering Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Shandong Shengli Bioengineering Recent Developments
12.10 Apeloa Pharmaceutical
12.10.1 Apeloa Pharmaceutical Company Information
12.10.2 Apeloa Pharmaceutical Overview
12.10.3 Apeloa Pharmaceutical Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Apeloa Pharmaceutical Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Apeloa Pharmaceutical Recent Developments
12.11 Hvsen Biotechnology
12.11.1 Hvsen Biotechnology Company Information
12.11.2 Hvsen Biotechnology Overview
12.11.3 Hvsen Biotechnology Enramycin Premix Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 Hvsen Biotechnology Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Hvsen Biotechnology Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Enramycin Premix Industry Chain Analysis
13.2 Enramycin Premix Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Enramycin Premix Production Mode & Process
13.4 Enramycin Premix Sales and Marketing
13.4.1 Enramycin Premix Sales Channels
13.4.2 Enramycin Premix Distributors
13.5 Enramycin Premix Customers
14 Enramycin Premix Market Dynamics
14.1 Enramycin Premix Industry Trends
14.2 Enramycin Premix Market Drivers
14.3 Enramycin Premix Market Challenges
14.4 Enramycin Premix Market Restraints
15 Key Finding in The Global Enramycin Premix Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Enramycin Premix Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of Contains Enramycin 4%
Table 3. Major Manufacturers of Contains Enramycin 8%
Table 4. Global Enramycin Premix Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global Enramycin Premix Production by Region: 2018 VS 2022 VS 2033 (K MT)
Table 6. Global Enramycin Premix Production by Region (2018-2023) & (K MT)
Table 7. Global Enramycin Premix Production by Region (2024-2033) & (K MT)
Table 8. Global Enramycin Premix Production Market Share by Region (2018-2023)
Table 9. Global Enramycin Premix Production Market Share by Region (2024-2033)
Table 10. Global Enramycin Premix Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 11. Global Enramycin Premix Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Enramycin Premix Revenue by Region (2024-2033) & (US$ Million)
Table 13. Global Enramycin Premix Revenue Market Share by Region (2018-2023)
Table 14. Global Enramycin Premix Revenue Market Share by Region (2024-2033)
Table 15. Global Enramycin Premix Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 16. Global Enramycin Premix Sales by Region (2018-2023) & (K MT)
Table 17. Global Enramycin Premix Sales by Region (2024-2033) & (K MT)
Table 18. Global Enramycin Premix Sales Market Share by Region (2018-2023)
Table 19. Global Enramycin Premix Sales Market Share by Region (2024-2033)
Table 20. Global Enramycin Premix Sales by Manufacturers (2018-2023) & (K MT)
Table 21. Global Enramycin Premix Sales Share by Manufacturers (2018-2023)
Table 22. Global Enramycin Premix Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Enramycin Premix Revenue Share by Manufacturers (2018-2023)
Table 24. Enramycin Premix Price by Manufacturers 2018-2023 (USD/MT)
Table 25. Global Key Players of Enramycin Premix, Industry Ranking, 2021 VS 2022 VS 2023
Table 26. Global Enramycin Premix Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Enramycin Premix by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enramycin Premix as of 2022)
Table 28. Global Key Manufacturers of Enramycin Premix, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Enramycin Premix, Product Offered and Application
Table 30. Global Key Manufacturers of Enramycin Premix, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 33. Global Enramycin Premix Sales by Type (2024-2033) & (K MT)
Table 34. Global Enramycin Premix Sales Share by Type (2018-2023)
Table 35. Global Enramycin Premix Sales Share by Type (2024-2033)
Table 36. Global Enramycin Premix Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Enramycin Premix Revenue by Type (2024-2033) & (US$ Million)
Table 38. Global Enramycin Premix Revenue Share by Type (2018-2023)
Table 39. Global Enramycin Premix Revenue Share by Type (2024-2033)
Table 40. Enramycin Premix Price by Type (2018-2023) & (USD/MT)
Table 41. Global Enramycin Premix Price Forecast by Type (2024-2033) & (USD/MT)
Table 42. Global Enramycin Premix Sales by Application (2018-2023) & (K MT)
Table 43. Global Enramycin Premix Sales by Application (2024-2033) & (K MT)
Table 44. Global Enramycin Premix Sales Share by Application (2018-2023)
Table 45. Global Enramycin Premix Sales Share by Application (2024-2033)
Table 46. Global Enramycin Premix Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Enramycin Premix Revenue by Application (2024-2033) & (US$ Million)
Table 48. Global Enramycin Premix Revenue Share by Application (2018-2023)
Table 49. Global Enramycin Premix Revenue Share by Application (2024-2033)
Table 50. Enramycin Premix Price by Application (2018-2023) & (USD/MT)
Table 51. Global Enramycin Premix Price Forecast by Application (2024-2033) & (USD/MT)
Table 52. US & Canada Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 53. US & Canada Enramycin Premix Sales by Type (2024-2033) & (K MT)
Table 54. US & Canada Enramycin Premix Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada Enramycin Premix Revenue by Type (2024-2033) & (US$ Million)
Table 56. US & Canada Enramycin Premix Sales by Application (2018-2023) & (K MT)
Table 57. US & Canada Enramycin Premix Sales by Application (2024-2033) & (K MT)
Table 58. US & Canada Enramycin Premix Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada Enramycin Premix Revenue by Application (2024-2033) & (US$ Million)
Table 60. US & Canada Enramycin Premix Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 61. US & Canada Enramycin Premix Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada Enramycin Premix Revenue by Country (2024-2033) & (US$ Million)
Table 63. US & Canada Enramycin Premix Sales by Country (2018-2023) & (K MT)
Table 64. US & Canada Enramycin Premix Sales by Country (2024-2033) & (K MT)
Table 65. Europe Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 66. Europe Enramycin Premix Sales by Type (2024-2033) & (K MT)
Table 67. Europe Enramycin Premix Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Enramycin Premix Revenue by Type (2024-2033) & (US$ Million)
Table 69. Europe Enramycin Premix Sales by Application (2018-2023) & (K MT)
Table 70. Europe Enramycin Premix Sales by Application (2024-2033) & (K MT)
Table 71. Europe Enramycin Premix Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Enramycin Premix Revenue by Application (2024-2033) & (US$ Million)
Table 73. Europe Enramycin Premix Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 74. Europe Enramycin Premix Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Enramycin Premix Revenue by Country (2024-2033) & (US$ Million)
Table 76. Europe Enramycin Premix Sales by Country (2018-2023) & (K MT)
Table 77. Europe Enramycin Premix Sales by Country (2024-2033) & (K MT)
Table 78. China Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 79. China Enramycin Premix Sales by Type (2024-2033) & (K MT)
Table 80. China Enramycin Premix Revenue by Type (2018-2023) & (US$ Million)
Table 81. China Enramycin Premix Revenue by Type (2024-2033) & (US$ Million)
Table 82. China Enramycin Premix Sales by Application (2018-2023) & (K MT)
Table 83. China Enramycin Premix Sales by Application (2024-2033) & (K MT)
Table 84. China Enramycin Premix Revenue by Application (2018-2023) & (US$ Million)
Table 85. China Enramycin Premix Revenue by Application (2024-2033) & (US$ Million)
Table 86. Asia Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 87. Asia Enramycin Premix Sales by Type (2024-2033) & (K MT)
Table 88. Asia Enramycin Premix Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia Enramycin Premix Revenue by Type (2024-2033) & (US$ Million)
Table 90. Asia Enramycin Premix Sales by Application (2018-2023) & (K MT)
Table 91. Asia Enramycin Premix Sales by Application (2024-2033) & (K MT)
Table 92. Asia Enramycin Premix Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia Enramycin Premix Revenue by Application (2024-2033) & (US$ Million)
Table 94. Asia Enramycin Premix Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 95. Asia Enramycin Premix Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia Enramycin Premix Revenue by Region (2024-2033) & (US$ Million)
Table 97. Asia Enramycin Premix Sales by Region (2018-2023) & (K MT)
Table 98. Asia Enramycin Premix Sales by Region (2024-2033) & (K MT)
Table 99. Middle East, Africa and Latin America Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 100. Middle East, Africa and Latin America Enramycin Premix Sales by Type (2024-2033) & (K MT)
Table 101. Middle East, Africa and Latin America Enramycin Premix Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Enramycin Premix Revenue by Type (2024-2033) & (US$ Million)
Table 103. Middle East, Africa and Latin America Enramycin Premix Sales by Application (2018-2023) & (K MT)
Table 104. Middle East, Africa and Latin America Enramycin Premix Sales by Application (2024-2033) & (K MT)
Table 105. Middle East, Africa and Latin America Enramycin Premix Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Enramycin Premix Revenue by Application (2024-2033) & (US$ Million)
Table 107. Middle East, Africa and Latin America Enramycin Premix Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 108. Middle East, Africa and Latin America Enramycin Premix Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Enramycin Premix Revenue by Country (2024-2033) & (US$ Million)
Table 110. Middle East, Africa and Latin America Enramycin Premix Sales by Country (2018-2023) & (K MT)
Table 111. Middle East, Africa and Latin America Enramycin Premix Sales by Country (2024-2033) & (K MT)
Table 112. Takeda Company Information
Table 113. Takeda Description and Major Businesses
Table 114. Takeda Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 115. Takeda Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Takeda Recent Development
Table 117. AdvaCare Company Information
Table 118. AdvaCare Description and Major Businesses
Table 119. AdvaCare Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 120. AdvaCare Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. AdvaCare Recent Development
Table 122. Phiphar Healthcare Company Information
Table 123. Phiphar Healthcare Description and Major Businesses
Table 124. Phiphar Healthcare Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 125. Phiphar Healthcare Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Phiphar Healthcare Recent Development
Table 127. Boehringer Ingelheim Company Information
Table 128. Boehringer Ingelheim Description and Major Businesses
Table 129. Boehringer Ingelheim Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 130. Boehringer Ingelheim Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Boehringer Ingelheim Recent Development
Table 132. Eli Lilly and Company Company Information
Table 133. Eli Lilly and Company Description and Major Businesses
Table 134. Eli Lilly and Company Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 135. Eli Lilly and Company Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eli Lilly and Company Recent Development
Table 137. Ravioza Biotech Company Information
Table 138. Ravioza Biotech Description and Major Businesses
Table 139. Ravioza Biotech Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 140. Ravioza Biotech Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ravioza Biotech Recent Development
Table 142. Zhejiang Dayang Biology Technology Company Information
Table 143. Zhejiang Dayang Biology Technology Description and Major Businesses
Table 144. Zhejiang Dayang Biology Technology Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 145. Zhejiang Dayang Biology Technology Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Zhejiang Dayang Biology Technology Recent Development
Table 147. Bornsun Bioengineering Company Information
Table 148. Bornsun Bioengineering Description and Major Businesses
Table 149. Bornsun Bioengineering Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 150. Bornsun Bioengineering Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Bornsun Bioengineering Recent Development
Table 152. Shandong Shengli Bioengineering Company Information
Table 153. Shandong Shengli Bioengineering Description and Major Businesses
Table 154. Shandong Shengli Bioengineering Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 155. Shandong Shengli Bioengineering Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Shandong Shengli Bioengineering Recent Development
Table 157. Apeloa Pharmaceutical Company Information
Table 158. Apeloa Pharmaceutical Description and Major Businesses
Table 159. Apeloa Pharmaceutical Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 160. Apeloa Pharmaceutical Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Apeloa Pharmaceutical Recent Development
Table 162. Hvsen Biotechnology Company Information
Table 163. Hvsen Biotechnology Description and Major Businesses
Table 164. Hvsen Biotechnology Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 165. Hvsen Biotechnology Enramycin Premix Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Hvsen Biotechnology Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Enramycin Premix Distributors List
Table 170. Enramycin Premix Customers List
Table 171. Enramycin Premix Market Trends
Table 172. Enramycin Premix Market Drivers
Table 173. Enramycin Premix Market Challenges
Table 174. Enramycin Premix Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Enramycin Premix Product Picture
Figure 2. Global Enramycin Premix Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Enramycin Premix Market Share by Type in 2022 & 2033
Figure 4. Contains Enramycin 4% Product Picture
Figure 5. Contains Enramycin 8% Product Picture
Figure 6. Global Enramycin Premix Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Enramycin Premix Market Share by Application in 2022 & 2033
Figure 8. Pig Fodder
Figure 9. Chicken Fodder
Figure 10. Others
Figure 11. Enramycin Premix Report Years Considered
Figure 12. Global Enramycin Premix Capacity, Production and Utilization (2018-2033) & (K MT)
Figure 13. Global Enramycin Premix Production Market Share by Region in Percentage: 2022 Versus 2033
Figure 14. Global Enramycin Premix Production Market Share by Region (2018-2033)
Figure 15. Enramycin Premix Production Growth Rate in North America (2018-2033) & (K MT)
Figure 16. Enramycin Premix Production Growth Rate in Europe (2018-2033) & (K MT)
Figure 17. Enramycin Premix Production Growth Rate in China (2018-2033) & (K MT)
Figure 18. Enramycin Premix Production Growth Rate in Japan (2018-2033) & (K MT)
Figure 19. Global Enramycin Premix Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global Enramycin Premix Revenue 2018-2033 (US$ Million)
Figure 21. Global Enramycin Premix Revenue (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Figure 22. Global Enramycin Premix Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 23. Global Enramycin Premix Revenue Market Share by Region (2018-2033)
Figure 24. Global Enramycin Premix Sales 2018-2033 ((K MT)
Figure 25. Global Enramycin Premix Sales (CAGR) by Region: 2018 VS 2022 VS 2033 (K MT)
Figure 26. Global Enramycin Premix Sales Market Share by Region (2018-2033)
Figure 27. US & Canada Enramycin Premix Sales YoY (2018-2033) & (K MT)
Figure 28. US & Canada Enramycin Premix Revenue YoY (2018-2033) & (US$ Million)
Figure 29. Europe Enramycin Premix Sales YoY (2018-2033) & (K MT)
Figure 30. Europe Enramycin Premix Revenue YoY (2018-2033) & (US$ Million)
Figure 31. China Enramycin Premix Sales YoY (2018-2033) & (K MT)
Figure 32. China Enramycin Premix Revenue YoY (2018-2033) & (US$ Million)
Figure 33. Asia (excluding China) Enramycin Premix Sales YoY (2018-2033) & (K MT)
Figure 34. Asia (excluding China) Enramycin Premix Revenue YoY (2018-2033) & (US$ Million)
Figure 35. Middle East, Africa and Latin America Enramycin Premix Sales YoY (2018-2033) & (K MT)
Figure 36. Middle East, Africa and Latin America Enramycin Premix Revenue YoY (2018-2033) & (US$ Million)
Figure 37. The Enramycin Premix Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 38. The Top 5 and 10 Largest Manufacturers of Enramycin Premix in the World: Market Share by Enramycin Premix Revenue in 2022
Figure 39. Global Enramycin Premix Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 40. Global Enramycin Premix Sales Market Share by Type (2018-2033)
Figure 41. Global Enramycin Premix Revenue Market Share by Type (2018-2033)
Figure 42. Global Enramycin Premix Sales Market Share by Application (2018-2033)
Figure 43. Global Enramycin Premix Revenue Market Share by Application (2018-2033)
Figure 44. US & Canada Enramycin Premix Sales Market Share by Type (2018-2033)
Figure 45. US & Canada Enramycin Premix Revenue Market Share by Type (2018-2033)
Figure 46. US & Canada Enramycin Premix Sales Market Share by Application (2018-2033)
Figure 47. US & Canada Enramycin Premix Revenue Market Share by Application (2018-2033)
Figure 48. US & Canada Enramycin Premix Revenue Share by Country (2018-2033)
Figure 49. US & Canada Enramycin Premix Sales Share by Country (2018-2033)
Figure 50. U.S. Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 51. Canada Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 52. Europe Enramycin Premix Sales Market Share by Type (2018-2033)
Figure 53. Europe Enramycin Premix Revenue Market Share by Type (2018-2033)
Figure 54. Europe Enramycin Premix Sales Market Share by Application (2018-2033)
Figure 55. Europe Enramycin Premix Revenue Market Share by Application (2018-2033)
Figure 56. Europe Enramycin Premix Revenue Share by Country (2018-2033)
Figure 57. Europe Enramycin Premix Sales Share by Country (2018-2033)
Figure 58. Germany Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 59. France Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 60. U.K. Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 61. Italy Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 62. Russia Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 63. China Enramycin Premix Sales Market Share by Type (2018-2033)
Figure 64. China Enramycin Premix Revenue Market Share by Type (2018-2033)
Figure 65. China Enramycin Premix Sales Market Share by Application (2018-2033)
Figure 66. China Enramycin Premix Revenue Market Share by Application (2018-2033)
Figure 67. Asia Enramycin Premix Sales Market Share by Type (2018-2033)
Figure 68. Asia Enramycin Premix Revenue Market Share by Type (2018-2033)
Figure 69. Asia Enramycin Premix Sales Market Share by Application (2018-2033)
Figure 70. Asia Enramycin Premix Revenue Market Share by Application (2018-2033)
Figure 71. Asia Enramycin Premix Revenue Share by Region (2018-2033)
Figure 72. Asia Enramycin Premix Sales Share by Region (2018-2033)
Figure 73. Japan Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 74. South Korea Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 75. China Taiwan Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 76. Southeast Asia Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 77. India Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Enramycin Premix Sales Market Share by Type (2018-2033)
Figure 79. Middle East, Africa and Latin America Enramycin Premix Revenue Market Share by Type (2018-2033)
Figure 80. Middle East, Africa and Latin America Enramycin Premix Sales Market Share by Application (2018-2033)
Figure 81. Middle East, Africa and Latin America Enramycin Premix Revenue Market Share by Application (2018-2033)
Figure 82. Middle East, Africa and Latin America Enramycin Premix Revenue Share by Country (2018-2033)
Figure 83. Middle East, Africa and Latin America Enramycin Premix Sales Share by Country (2018-2033)
Figure 84. Brazil Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 85. Mexico Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 86. Turkey Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 87. Israel Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 88. GCC Countries Enramycin Premix Revenue (2018-2033) & (US$ Million)
Figure 89. Enramycin Premix Value Chain
Figure 90. Enramycin Premix Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed